This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
High Bleeding Risk, Coronary Artery Disease or PCI
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The study compares two lengths of medication therapy (a shortened versus a prolonged dual antiplatelet therapy) in order to prevent thrombus (blood cloth) formation after the successfully treatment for coronary heart disease with a drug covered stent (metallic tube). This comparison will be done in patients who, compared to the average patient, are more likely to suffer from complications on antiplatelet therapy (bleeding). Both durations are within the current medical recommendations. The aim of this study is to help improve further standard antiplatelet duration guidelines.

Provided treatments

  • Drug: Aspirin
  • Drug: P2Y12 inhibitor
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023020. The sponsor of the trial is ECRI bv and it is looking for 4300 volunteers for the current phase.
Official trial title:
Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen